Vessella RL - Search Results

1

Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases.

Morrissey C, Kostenuik PL, Brown LG, Vessella RL, Corey E. Morrissey C, et al. Among authors: vessella rl. BMC Cancer. 2007 Aug 3;7:148. doi: 10.1186/1471-2407-7-148. BMC Cancer. 2007. PMID: 17683568 Free PMC article.

2

Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol.

Corey E, Quinn JE, Emond MJ, Buhler KR, Brown LG, Vessella RL. Corey E, et al. Among authors: vessella rl. Clin Cancer Res. 2002 Apr;8(4):1003-7. Clin Cancer Res. 2002. PMID: 11948106

3

Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells.

Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL. Corey E, et al. Among authors: vessella rl. Prostate. 2002 Jun 1;52(1):20-33. doi: 10.1002/pros.10091. Prostate. 2002. PMID: 11992617

4

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.

Corey E, Brown LG, Quinn JE, Poot M, Roudier MP, Higano CS, Vessella RL. Corey E, et al. Among authors: vessella rl. Clin Cancer Res. 2003 Jan;9(1):295-306. Clin Cancer Res. 2003. PMID: 12538482

5

Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia.

Wang Z, Corey E, Hass GM, Higano CS, True LD, Wallace D Jr, Tisdale MJ, Vessella RL. Wang Z, et al. Among authors: vessella rl. Int J Cancer. 2003 May 20;105(1):123-9. doi: 10.1002/ijc.11035. Int J Cancer. 2003. PMID: 12672042

6

A novel method of generating prostate cancer metastases from orthotopic implants.

Corey E, Quinn JE, Vessella RL. Corey E, et al. Among authors: vessella rl. Prostate. 2003 Jul 1;56(2):110-4. doi: 10.1002/pros.10235. Prostate. 2003. PMID: 12746835

7

Characterization of C4-2 prostate cancer bone metastases and their response to castration.

Pfitzenmaier J, Quinn JE, Odman AM, Zhang J, Keller ET, Vessella RL, Corey E. Pfitzenmaier J, et al. Among authors: vessella rl. J Bone Miner Res. 2003 Oct;18(10):1882-8. doi: 10.1359/jbmr.2003.18.10.1882. J Bone Miner Res. 2003. PMID: 14584899 Free article.

8

Osteoprotegerin in prostate cancer bone metastasis.

Corey E, Brown LG, Kiefer JA, Quinn JE, Pitts TE, Blair JM, Vessella RL. Corey E, et al. Among authors: vessella rl. Cancer Res. 2005 Mar 1;65(5):1710-8. doi: 10.1158/0008-5472.CAN-04-2033. Cancer Res. 2005. PMID: 15753366

9

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment.

Brubaker KD, Brown LG, Vessella RL, Corey E. Brubaker KD, et al. Among authors: vessella rl. BMC Cancer. 2006 Jan 17;6:15. doi: 10.1186/1471-2407-6-15. BMC Cancer. 2006. PMID: 16417633 Free PMC article.

10

Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.

Vessella RL, Corey E. Vessella RL, et al. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6285s-6290s. doi: 10.1158/1078-0432.CCR-06-0813. Clin Cancer Res. 2006. PMID: 17062715 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters